We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

LDC and Boehringer Ingelheim Join Forces

News   May 11, 2016

 
LDC and Boehringer Ingelheim Join Forces
 
 
Advertisement
 

RELATED ARTICLES

Mouthwash Could Reduce SARS-CoV-2 Short-Term Viral Load, Cell Culture Study Suggests

News

Results from cell culture experiments show that commercially available preparations have an effect on Sars-Cov-2 viruses.

READ MORE

New Process Accelerates Synthesis of Antiviral and Anticancer Drugs

News

Using a new process, scientists can create new nucleoside analogues months earlier than with the previous method, paving the way for quicker drug discoveries.

READ MORE

Recreating Nature: Chemists Create Synthetic Version of Natural Anti-Cancer Agent

News

Scripps Research chemists Hans Renata, PhD, and Alexander Adibekian, PhD, have discovered a way to efficiently create a synthetic version of a valuable natural compound called cepafungin I, which has shown promise as an anti-cancer agent.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE